Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence
Aromatase Inhibitors drug, Femara
given after 5 years of Tamoxifen therapy is found to give protection against occurrence of Breast cancer recurrence. Breast cancer is the second leading cause of cancer// in women. Breast cancer mostly occurs in post menopausal women and various risk factors are at...
Hormone Drug Type Makes Survival Difference in Advanced Breast Cancer
... hormone treatments, according to a new systematic review of studies.
In addition, aromatase inhibitors — drugs known as Arimidex, Aromasin and femara
— are less likely to cause blood clots and vaginal bleeding than other hormone treatments, said review co-author Judith Bliss of the Institute of Canc...
NICE Approves The New Class Of Breast Cancer Drugs
It was reported that the three drugs were Arimidex (anastrozole), femara
(letrozole), and Aromasin (exemestane) and will be available on the NHS alo...er to the 50% reduction provided by Tamoxifen. Studies have also shown that femara
is also more effective than Tamoxifen in a number of studies. The governmen...
Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
... The U.S. Food and Drug Administration (FDA) have approved the drug femara
(letrozole) as drug for the treatment of patients suffering from breast can...ssue of New England Journal of Medicine.
It said that the Novartis drug femara
was very efficient in controlling the recurrence of breast cancer among pos...
New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
...Journal of Medicine says that a new drug called as femara
is better than tamoxifen fro preventing the chances // of a relapse of breast cancer. femara
is a drug manufactured by Novartis AG and is chemi...king either tamoxifen or Femara. It was found that femara
reduced the chances of breast cancer relapse by 29...
Letrozole Beats Tamoxifen in Breast Cancer Therapy
... Novartis' femara
(letrozole), one of a new class of breast cancer d...ng breast cancer in women// with advanced disease. femara
is a member of a new class of drugs called aromata...The US Food and Drug Administration (FDA) approved femara
as first-line hormonal treatment for advanced brea...
Femara in Medical Technology
Newly Published Study Reveals Femara Improves Chances for Harder to
Treat Early Breast Cancer Relapse in Postmenopausal Women
FRIMLEY, SURREY, England, April 30, 2007 /PRNewswire-FirstCall/
reduces the risk of breast cancer spreading to the
lungs, the brain or the bone which has a worse prognosis than when
the cancer is localised to the breast
Newly published data in the May issue of Annals of Oncology,
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
... advanced HCC is in development by Novartis.
BIG 1-98 data on cognitive function
Impaired co...eptor-positive early breast cancer taking adjuvant femara
had better overall cognitive function than those t...tudy revealed that the group of patients receiving femara
had clinically and significantly better overall co...
Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
... - femara
showed reduced risk of death by 13% (P=0.08), desp...lusion of patients crossing over from tamoxifen to femara
- In a separate censored analysis...ndependent BIG 1-98 trial reinforces starting with femara
as the optimal treatment strategy versus tamoxifen...
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
...report on optimal post-surgery treatment strategy, femara
- Multiple Zometa studies a...from major international BIG 1-98 trial evaluating femara
vs. tamoxifen and the sequencing of the two therap... please visit www.us.exjade.com .
Femara(R) (letrozole tablets) is approved for...
Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
early stage breast cancer. The benefits of femara
in clinical trials are
based on 24 months of treat...termine long- term results, safety and efficacy.
is also approved for the extended adjuvant treatme...f five years of tamoxifen therapy. The benefits of femara
clinical trials are based on 24 months of treat...
VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
...ides evidence for
potential benefit of starting femara
up to seven years after finishing tamoxifen
only member of aromatase inhibitor class with data...s of Oncology affirms significant advantages of femara
when taken after standard tamoxifen therapy